No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Moderna explained that it began Phase 1/2 testing of mRNA-1018 in 2023 in healthy adults aged 18 and up, including candidates against the H5 and H7 avian influenza viruses. It noted that based on ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.